Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

University of Connecticut School of Pharmacy

Perioperative Management of Warfarin Interruption

Access Activity

Overview / Abstract:
In this application-based continuing pharmacy education activity Dr. Victoria Lambert, PharmD, CACP discuss the important aspects of utilizing bridge therapy for patients on long-term anticoagulation.
Target Audience
Pharmacists who are interested in the management of patients on anticoagulation therapy and/or who are interested in starting pharmacy services for patients on anticoagulation therapy.
This activity is not accredited for technicians.
Learning Objectives
At the conclusion of the activity, pharmacists will be able to:

Review recommendations for when to interrupt warfarin therapy
Review guidelines for determining thromboembolic risk
Review recommendations for bridging therapy implementation
Review cases for appropriate method to manage warfarain interruption based on risk stratification.
Apply case-specific monitoring parameters for anticoagulation bridge therapy

Expiration

May 15, 2019

Discipline(s)

Pharmacy CPE

Format

Online, Seminar

Cost

$15

Credits / Hours

1.0 Continuing Education hours

Accreditation

ACPE

Presenters / Authors / Faculty

Victoria Lambert, Pharm.D.,CACP
William W. Backus Hospital, Norwich, CT

Activity Specialities / Related Topics

Anticoagulation / Thrombosis

Keywords / Search Terms

University of Connecticut School of Pharmacy University of Connecticut School of Pharmacy, University of Connecticut School of Pharmacy Anticoagulation, Anticoagulation Therapy, Warfarin, Bridge Therapy

Access Activity

YouTube Google+ Pinterest Twitter LinkedIn Facebook SlideShare
RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.